¡Ya estamos en ! Descubre más
27.42 USD
-0.61
2.18%
Al cierre Actualizado 16 oct, 4:00 p.m. EDT
1 día
-2.18%
5 días
-0.94%
1 mes
4.86%
3 meses
-35.93%
6 meses
8%
En lo que va del año
0.11%
1 año
12.79%
5 años
154.12%
10 años
523.18%
 

Acerca de: Electromed Inc is a United States-based company that develops, manufactures and markets airway clearance products that apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ages. The company markets its products in the U.S. to the homecare and hospital markets. Its product includes the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The company operates in a single segment: developing, manufacturing, and marketing medical equipment. The company generates revenue from Homecare, Hospital, Homecare Distributor, and Other.

Empleados: 197

Noticias

Positivo
Neutral
Negativo
Sentimiento 3 meses
Positivo 28.6%
Neutral 71.4%
Negativo 0%
Neutral
Business Wire
el mes pasado
Electromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main Event
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main Event.
Electromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main Event
Positivo
Seeking Alpha
el mes pasado
Electromed: Contrarian 'Buy' With SmartVest
Electromed's direct-to-patient model, broad payer coverage, and disciplined sales execution support durable SmartVest growth. The bronchiectasis market remains substantially underpenetrated, leaving a long runway for greater HFCWO adoption. Hospital revenue is volatile, but the channel remains small and full-year hospital sales still increased.
Electromed: Contrarian 'Buy' With SmartVest
Neutral
Seeking Alpha
el mes pasado
Electromed, Inc. (ELMD) Q4 2026 Earnings Call Transcript
Electromed, Inc. (ELMD) Q4 2026 Earnings Call Transcript
Electromed, Inc. (ELMD) Q4 2026 Earnings Call Transcript
Positivo
Zacks Investment Research
el mes pasado
Electromed, Inc. (ELMD) Surpasses Q4 Earnings Estimates
Electromed, Inc. (ELMD) came out with quarterly earnings of $0.39 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.25 per share a year ago.
Electromed, Inc. (ELMD) Surpasses Q4 Earnings Estimates
Neutral
Business Wire
el mes pasado
Electromed Announces CEO's Planned Retirement
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed Announces CEO's Planned Retirement.
Electromed Announces CEO's Planned Retirement
Neutral
Business Wire
el mes pasado
Electromed, Inc. Announces Record Fiscal 2026 Fourth Quarter and Full Year Financial Results
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Record Fiscal 2026 Fourth Quarter and Full Year Financial Results.
Electromed, Inc. Announces Record Fiscal 2026 Fourth Quarter and Full Year Financial Results
Neutral
Business Wire
hace 2 meses
Electromed, Inc. to Report Q4 Fiscal 2026 Financial Results on August 25, 2026
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Report Q4 Fiscal 2026 Financial Results on August 25, 2026.
Electromed, Inc. to Report Q4 Fiscal 2026 Financial Results on August 25, 2026
Positivo
Zacks Investment Research
hace 3 meses
4 Low-Beta Stocks to Minimize Portfolio Risk: LQDA, FLXS, ELMD & AGX
LQDA, FLXS, ELMD and AGX combine low beta, positive price momentum and strong fundamentals to help investors navigate market volatility.
4 Low-Beta Stocks to Minimize Portfolio Risk: LQDA, FLXS, ELMD & AGX
Positivo
Zacks Investment Research
hace 3 meses
Electromed (ELMD) Is a Great Choice for 'Trend' Investors, Here's Why
Electromed (ELMD) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Electromed (ELMD) Is a Great Choice for 'Trend' Investors, Here's Why
Positivo
Zacks Investment Research
hace 3 meses
Here's Why Momentum in Electromed (ELMD) Should Keep going
If you are looking for stocks that are well positioned to maintain their recent uptrend, Electromed (ELMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Here's Why Momentum in Electromed (ELMD) Should Keep going
Gráficos de precios implementados con Lightweight Charts™